APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin
Clinical trial NCT02850289 · COMPLETED
Trial details
- NCT number
- NCT02850289
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2006-04-01
- Primary completion
- 2008-10-01
- Enrollment
- 385
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.